Hastings Innovation Award for Interstitial Lung Disease Award - American Lung Association
This grant funds innovative research by accomplished investigators to advance scientific understanding and clinical care for interstitial lung disease.
Funder: American Lung Association
Due Dates (Anticipated): December 2026
Funding Amounts: $75,000/year for up to 2 years (maximum $150,000 total); no indirect costs allowed
Summary: Supports innovative research by promising investigators to advance interstitial lung disease science, emphasizing scientific merit and impact on lung health.
Key Information: This is a forecasted opportunity; eligibility requires prior NIH K or R award within 5 years and U.S. employment authorization.
Description
The Hastings Innovation Award for Interstitial Lung Disease, offered by the American Lung Association, is designed to support highly promising investigators with strong records of accomplishment in advancing lung disease science. The award aims to foster innovative research that can drive new discoveries, improve scientific knowledge, and enhance clinical practice related to interstitial lung disease. The program prioritizes scientific merit, technical feasibility, innovation in approach and methodology, and the potential impact on lung health.
